A Case Series on the Use of Brentuximab Vedotin for the Treatment of Mycosis Fungoides

Conclusions: Improved understanding of appropriate CD30 testing and evaluation will allow for quicker invention of patients with BV responsive CTCL.  J Drugs Dermatol. 2023;22(12):e33-e34.    doi:10.36849/JDD.6981e.PMID:38051830 | DOI:10.36849/JDD.6981

Source: Journal of Drugs in Dermatology - December 5, 2023 Category: Dermatology Authors: Katherine A Kelly Leah Edenfield Mary Beth Seegars Rakhee Vaidya Steven R Feldman Lindsay C Strowd Source Type: research